Results 261 to 270 of about 35,539 (289)

Combined Vaccine Against Measles, Mumps, Rubella, and Varicella

Pediatrics, 1988
A combined measles, mumps, rubella, and varicella vaccine produced seroconversions for all four components similar to that found if measles, mumps, and rubella vaccine or live varicella vaccine were given separately. In addition, those exposed to varicella were completely protected or had only a mild rash.
Valerio M. Novelli, Philip A. Brunell, Susan V. Lipton, Betsy Pollock   +3 more
openaire   +3 more sources

Autism and Measles-Mumps-Rubella Vaccination

CNS Drugs, 2001
It has been suggested that vaccination, particularly with measles-mumps-rubella (MMR) vaccine, may be related to the development of autism. The main evidence for a possible association is that the prevalence of autism has been increasing at the same time that infant vaccination coverage has increased, and that in some cases there is an apparent ...
Frank DeStefano, Robert T. Chen
openaire   +3 more sources

Pityriasis lichenoides triggered by measles‐mumps‐rubella vaccine injection

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
No
Filippi F., Patrizi A., Sabattini E., Varotti E., Bertuzzi C., Pileri A.   +5 more
openaire   +3 more sources

A new combination vaccine for measles, mumps, rubella and varicella

Drugs of Today, 2006
ProQuad is a recently approved combination vaccine for simultaneous vaccination against measles, mumps, rubella and varicella in children aged 12 months to 12 years. It combines two well-established vaccines: Measles, Mumps, Rubella Virus Vaccine Live (M-M-R II) and Varicella Virus Vaccine Live (Varivax with higher varicella-zoster titer).
openaire   +3 more sources

Egg Hypersensitivity and Measles-Mumps-Rubella Vaccine Administration

Pediatrics, 1991
Because reports have described egg-sensitive individuals in whom anaphylaxis developed after measles vaccination, current recommendations include delaying administration of egg-derived vaccines until skin testing can be performed. Specifically, the 1988 Red Book recommends skin testing via scratch, prick, or puncture with 1:10 dilution of the vaccine ...
S A, Beck, L W, Williams, M A, Shirrell, A W, Burks   +3 more
openaire   +2 more sources

Combined Live Measles, Mumps, Rubella Vaccine

American Journal of Diseases of Children, 1971
A combined live attenuated measles, mumps, rubella vaccine was administered to 40 susceptible (seronegative) infants, 12 to 26 months of age. The antibody responses to the three viruses were excellent and the vaccine was well tolerated.
Vincent J. Fontana, Gloria Muriel, Saul Krugman   +2 more
openaire   +3 more sources

What is the cause of a rash after measles–mumps–rubella vaccination?

Medical Journal of Australia, 1999
Surveillance and laboratory confirmation of measles will increase in importance as Australia implements enhanced measles control. We describe a 17-month-old child with fever and rash after measles-mumps-rubella vaccination. Detection of vaccine-strain measles virus in his urine by polymerase chain reaction confirmed the diagnosis of a vaccine reaction ...
Pauline A. Lynch, G A Jenkin, H A Kelly, D Chibo, Michael G Catton   +4 more
openaire   +3 more sources

On-line Documentation of Measles-Mumps-Rubella Vaccine Inoculation

Archives of Pediatrics & Adolescent Medicine, 1985
Sir .—In 1984, at the time of a measles outbreak among students at Dartmouth College, Hanover, NH, an audit of 4,903 student health records revealed that 59.6% lacked adequate documentation of measles immunity. The overall attack rate among the students was 0.7% (varying from 3.2% to 0.6%) during the outbreak, yet an extensive vaccination program was ...
openaire   +3 more sources

Depressed Lymphocyte Function after Measles-Mumps-Rubella Vaccination

Journal of Infectious Diseases, 1975
Healthy children receiving routine measles-mumps-rubella vaccine developed an impaired in vitro lymphocyte response to stimulation with antigen (Candida) but not with mitogen (phytohemagglutinin and pokeweed mitogen). Response of lymphocytes was determined by measurement of the amount of [14C]thymidine incorporated by the cells.
Fred S. Kantor, Thomas F. Dolan, Thomas P. Munyer, Richard J. Mangi   +3 more
openaire   +3 more sources

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

The Pediatric Infectious Disease Journal, 1996
BACKGROUND Since 1989 the American Academy of Pediatrics and the ACIP have recommended a second dose of measles-mumps-rubella vaccine (M-M-R-II) at either school entry or age 11 to 13 years. Unfortunately few studies are available to compare responses to
Candice E. Johnson, Mary L. Kumar, J. Whitwell, B. Staehle, L. Rome, C. Dinakar, W. Hurni, D. Nalin   +7 more
semanticscholar   +1 more source